Artal Group S.A. Recursion Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $3.65 Million - $6.48 Million	510,204 Added 113.38%	960,204 $7.4 Million
Q1 2022 May 12, 2022	BUY	$6.16 - $18.03 $1.54 Million - $4.51 Million	250,000 Added 125.0%	450,000 $3.22 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $3.6 Million - $7.48 Million	200,000 New	200,000 $7.3 Million

289

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.18B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.